Product Details for: Merilog

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
1,000UNITS/10ML (100UNITS/ML)
Multi-Dose Vial
351(k) Biosimilar
Merilog
Rx
002
Injection
Subcutaneous
300UNITS/3ML (100UNITS/ML)
Autoinjector
351(k) Biosimilar
Merilog
Rx
Proper Name
insulin aspart-szjj
Reference Product Proper Name
insulin aspart
Reference Product Properietary Name
Novolog
BLA Number
761325
Applicant
Sanofi-Aventis U.S. LLC
Original Approval Date
February 14, 2025
Date of First Licensure
RETURN TO SEARCH RESULTS